» Articles » PMID: 36612810

Underdiagnosis in Background of Emerging Public Health Challenges Related to Peri-Implant Diseases: An Interventional Split-Mouth Study

Overview
Publisher MDPI
Date 2023 Jan 8
PMID 36612810
Authors
Affiliations
Soon will be listed here.
Abstract

Peri-implant diseases are an emerging public health problem, and it's considered that limitations of standard diagnostics play the role herein. The study objective was the estimation of pathological bone resorption at clinical and biological level in patients with peri-implant mucositis (PIM) and peri-implantitis (PI) before and 6 months after standard treatment and to compare them with healthy controls (HC). The split-mouth interventional study included 60 patients affected with PIM or PI. Patients that also presented at least one more HC were enrolled in the study and underwent standard non-surgical and surgical treatment, respectively. Standard clinical parameters and soluble levels of RANKL were measured in peri-implant crevicular fluid baseline and 6 months following treatment. Clinical parameters and RANKL significantly decreased following treatment in PIM and PI. However, bleeding on probing and probing depth remained significantly increased when compared to HC. RANKL answered requests for biomarker of peri-implant diseases, its baseline levels were significantly increased in PIM and PI, they decreased following treatment and reached HC in peri-implantitis, while in PIM RANKL remained significantly increased. Presence of pathological bone resorption in patients lacked its clinical signs, and respective persistence following treatment suggest the need for biomarker-supported diagnosis for timely diagnosis of peri-implantitis and appropriate orientation of respective management strategies.

References
1.
Schwarz F, Derks J, Monje A, Wang H . Peri-implantitis. J Clin Periodontol. 2018; 45 Suppl 20:S246-S266. DOI: 10.1111/jcpe.12954. View

2.
Jepsen S, Berglundh T, Genco R, Aass A, Demirel K, Derks J . Primary prevention of peri-implantitis: managing peri-implant mucositis. J Clin Periodontol. 2015; 42 Suppl 16:S152-7. DOI: 10.1111/jcpe.12369. View

3.
Carinci F, Romanos G, Scapoli L . Molecular tools for preventing and improving diagnosis of peri-implant diseases. Periodontol 2000. 2019; 81(1):41-47. DOI: 10.1111/prd.12281. View

4.
Berglundh T, Armitage G, Araujo M, Avila-Ortiz G, Blanco J, Camargo P . Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol. 2018; 45 Suppl 20:S286-S291. DOI: 10.1111/jcpe.12957. View

5.
Theoleyre S, Wittrant Y, Tat S, Fortun Y, Redini F, Heymann D . The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004; 15(6):457-75. DOI: 10.1016/j.cytogfr.2004.06.004. View